ResMed (ASX:RMD) Chief Executive Michael Farrel sold 8,009 shares on the New York Stock Exchange for $2 million in total, according to a Tuesday filing with the Australian bourse.
Following the sale of shares, Farrel owns about 146.6 million shares in the company, per the filing.
The company's shares rose 1% in recent Tuesday trade.